These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9532316)

  • 1. Neurological manifestations of chronic myelogenous leukaemia.
    Aken'Ova YA; Okunade MA; Akang EE
    Afr J Med Med Sci; 1996 Dec; 25(4):397-8. PubMed ID: 9532316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraplegia as the presenting manifestation of extramedullary megakaryoblastic transformation of previously undiagnosed chronic myelogenous leukemia.
    Bryant BJ; Alperin JB; Elghetany MT
    Am J Hematol; 2007 Feb; 82(2):150-4. PubMed ID: 17019692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden bilateral deafness from hyperleukocytosis in chronic myeloid leukemia.
    Resende LS; Coradazzi AL; Rocha-Júnior C; Zanini JM; Niéro-Melo L
    Acta Haematol; 2000; 104(1):46-9. PubMed ID: 11111123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden onset bilateral deafness as a presentation of chronic myeloid leukaemia.
    Alimam SM; Mamat MK; Kulkarni S; Somervaille TC
    Br J Haematol; 2013 Jan; 160(1):3. PubMed ID: 23110352
    [No Abstract]   [Full Text] [Related]  

  • 5. Hearing loss in chronic myeloid leukemia.
    Naithani R; Chandra J; Mathur NN; Narayan S; Singh V
    Pediatr Blood Cancer; 2005 Jul; 45(1):54-6. PubMed ID: 15761879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic myelogenous leukemia with marked thrombocytosis].
    Hasegawa T; Hino M; Yamane T; Ota K; Takubo T; Kitagawa S; Tatsumi N
    Rinsho Ketsueki; 2001 Mar; 42(3):199-203. PubMed ID: 11345782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual loss as initial presentation of chronic myelogenous leukemia.
    Mandić BD; Potocnjak V; Bencić G; Mandić Z; Pentz A; Hajnzić TF
    Coll Antropol; 2005; 29 Suppl 1():141-3. PubMed ID: 16193698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological complications of chronic myeloid leukaemia: any cure?
    Joseph DE; Durosinmi MA
    Niger J Clin Pract; 2008 Sep; 11(3):246-9. PubMed ID: 19140362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature.
    Vaiopoulos G; Terpos E; Viniou N; Nodaros K; Rombos J; Loukopoulos D
    Am J Hematol; 2001 Jan; 66(1):57-8. PubMed ID: 11426495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on relationship between different bcr/abl fusion transcripts and clinical manifestations in chronic myeloid leukemia].
    Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Qiu JY; Lu DP; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):347-50. PubMed ID: 12941187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Priapism complicated by chronic myelogenous leukemia (CML); a case report].
    Yoshida K; Kinoshita H; Taniguti H; Chizaki R; Nishida T; Kawakita S; Hiura Y; Ooguti N; Kawa G; Muguruma K; Matsuda T
    Hinyokika Kiyo; 2007 May; 53(5):323-5. PubMed ID: 17561719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoid preponderance and the absence of basophilia and splenomegaly are frequent in m-bcr-positive chronic myelogenous leukemia.
    Hur M; Song EY; Kang SH; Shin DH; Kim JY; Park SS; Cho HI
    Ann Hematol; 2002 Apr; 81(4):219-23. PubMed ID: 11976825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperfunction of neutrophils in a patient with BCR/ABL negative chronic myeloid leukemia: a case report with in vitro studies.
    Watari K; Tojo A; Nagamura-Inoue T; Matsuoka M; Irie S; Tani K; Yamada Y; Asano S
    Cancer; 2000 Aug; 89(3):551-60. PubMed ID: 10931454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aseptic necrosis of both femoral heads as first symptom of chronic myelogenous leukemia.
    Kraemer M; Weissinger F; Kraus R; Beer M; Kunzmann V; Wilhelm M
    Ann Hematol; 2003 Jan; 82(1):44-6. PubMed ID: 12574965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Central nervous system and organ infiltration in the chronic phase of chronic myelogenous leukemia: a case report].
    Krupiński A; Zduńczyk A; Banaś L; Kałuza J
    Wiad Lek; 1999; 52(9-10):508-12. PubMed ID: 10628277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of co-expressing M-bcr/abl and m-bcr/abl fusion gene transcripts on the clinical features of patients with chronic myelogenous leukemia at diagnosis].
    Meng WT; Liu T; Li JJ; Shi Q; Yu J; Cui X; Wu Y; Xiang B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):97-100. PubMed ID: 16468653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
    Ren R
    Nat Rev Cancer; 2005 Mar; 5(3):172-83. PubMed ID: 15719031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of BCR/ABL transcript variants with patients' characteristics in childhood chronic myeloid leukaemia.
    Adler R; Viehmann S; Kuhlisch E; Martiniak Y; Röttgers S; Harbott J; Suttorp M
    Eur J Haematol; 2009 Feb; 82(2):112-8. PubMed ID: 19067742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.